Search Results

You are looking at 221 - 230 of 1,243 items for :

  • Refine by Access: All x
Clear All
Full access

Venkata K. Pokuri, Houman Nourkeyhani, Bodie Betsy, Laurie Herbst, Marcus Sikorski, Edward Spangenthal, Andrew Fabiano, and Saby George

margins were negative. His PSA level was 10 ng/mL before surgery and decreased to less than 0.01 ng/mL after prostatectomy. After surgery he was lost to follow-up. Seven years later, he presented with 3 weeks of gait unsteadiness associated with back pain

Full access

R. Michael Tuttle, Douglas W. Ball, David Byrd, Raza A. Dilawari, Gerard M. Doherty, Quan-Yang Duh, Hormoz Ehya, William B. Farrar, Robert I. Haddad, Fouad Kandeel, Richard T. Kloos, Peter Kopp, Dominick M. Lamonica, Thom R. Loree, William M. Lydiatt, Judith C. McCaffrey, John A. Olson Jr., Lee Parks, John A. Ridge, Jatin P. Shah, Steven I. Sherman, Cord Sturgeon, Steven G. Waguespack, Thomas N. Wang, and Lori J. Wirth

years and older. 1 – 3 Nodules are even more prevalent when the thyroid gland is examined at autopsy or surgery, or when using ultrasonography, and 50% of these have nodules, which are almost always benign. 2 , 4 New nodules develop at a rate of

Full access

Saber Amin, Michael Baine, Jane Meza, and Chi Lin

, with a median survival time of 4 to 16 months, depending on the primary site. 4 – 6 Current treatment modalities available for the treatment of BMs are surgery, whole-brain radiation therapy (RT), and stereotactic radiosurgery (SRS). 7 , 8 The most

Full access

vivo tumor cellularity. Patients are evaluated for surgery 6 weeks after chemoradiotherapy. Patients with resectable disease proceed to surgery; those with unresectable disease may receive oral vorinostat once daily and oral capecitabine twice daily

Full access

Frank Qian Zhan, Vathani Sharon Packianathan, and Nathalie Charlotte Zeitouni

. Comparison of Mohs micrographic surgery and wide excision in eighty-six patients . Dermatol Surg 1997 ; 23 : 929 – 933 . 66 Boyer JD Zitelli JA Brodland DG D’Angelo G . Local control of primary Merkel cell carcinoma: review of 45 cases treated

Full access

Jeffrey S. Dome, Elizabeth A. Mullen, David B. Dix, Eric J. Gratias, Peter F. Ehrlich, Najat C. Daw, James I. Geller, Murali Chintagumpala, Geetika Khanna, John A. Kalapurakal, Lindsay A. Renfro, Elizabeth J. Perlman, Paul E. Grundy, and Conrad V. Fernandez

.1%, indicating that the interventions were effective ( Table 2 ). 23 A total of 39% of patients were able to undergo bilateral nephron-sparing surgery and only 1% (n=2) became anephric; 84% of patients underwent definitive surgical treatment (partial or complete

Full access

Ang Li, Qian Wu, Suhong Luo, Greg S. Warnick, Neil A. Zakai, Edward N. Libby, Brian F. Gage, David A. Garcia, Gary H. Lyman, and Kristen M. Sanfilippo

, diabetes, hypertension, renal disease, liver disease, immobilization (paralysis/hemiplegia), blood clotting disorders (coagulopathy), anemia, history of VTE, history of bleeding, central venous catheter, recent sepsis, surgery, and traumatic injury were

Full access

M. Zach Koontz, Brendan M. Visser, and Pamela L. Kunz

most patients treated up to the day before surgery), and the estimated overall survival at 3 years was 84%. 15 The low response rates in this study may be a function of declaring the appropriate imaging modality or response criteria. Choi et al 16

Full access

Ami Vyas, S. Suresh Madhavan, Usha Sambamoorthi, Xiaoyun (Lucy) Pan, Michael Regier, Hannah Hazard, and Sita Kalidindi

.5 billion, the initial phase of care (12 months) following BC diagnosis represented 37% of the cost, the continuing phase of care 41%, and the last year of life accounted for 22%. BC costs are substantially higher for the initial phase of care due to surgery

Full access

Vivek Verma, Amy C. Moreno, Waqar Haque, Penny Fang, and Steven H. Lin

Despite continual efforts to improve prognosis and decrease treatment-related toxicities, non–small cell lung cancer (NSCLC) remains a major health epidemic worldwide. NSCLC is commonly treated with upfront surgery with or without prior induction